Search

Sartorius Stedim Biotech.

Geschlossen

BrancheFinanzen

189.3 -0.84

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

186.1

Max

190.9

Schlüsselkennzahlen

By Trading Economics

Einkommen

4.9M

93M

Verkäufe

4.2M

766M

KGV

Branchendurchschnitt

61.96

21.734

EPS

1.25

Dividendenrendite

0.36

Gewinnspanne

12.146

Angestellte

10,477

EBITDA

9.2M

240M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+26.05% upside

Dividenden

By Acuity

Dividendenrendite

Branchendurchschnitt

0.36%

4.42%

Nächstes Ergebnis

22. Okt. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

611M

18B

Vorheriger Eröffnungskurs

190.14

Vorheriger Schlusskurs

189.3

Nachrichtenstimmung

By Acuity

34%

66%

82 / 436 Ranking in Finance

Sartorius Stedim Biotech. Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Sept. 2026, 23:56 UTC

News

Korn Ferry's Board declared a quarterly cash dividend of $0.55 per share, payable October 15. Shares traded roughly flat in after-market hours.

8. Sept. 2026, 23:56 UTC

Social Media
News

Chevron Corp shares are higher in after-market hours following a report on declining OECD strategic petroleum reserves, which may impact oil prices and benefit the company.

8. Sept. 2026, 23:46 UTC

News
Social Media

Warner Bros Discovery Inc. shares are higher in after-market hours following Paramount Skydance's court filings on merger progress, indicating potential $1.88 billion impact.

8. Sept. 2026, 23:41 UTC

News

BJ's Restaurants shares are trading lower in after-market hours following a presentation at the Barclays Consumer Staples Conference focused on a strategic reset.

8. Sept. 2026, 23:41 UTC

News

Boston Beer Company appointed Allison Stransky as Chief Marketing Officer, effective October 12, 2026. Shares are trading higher in after-market hours.

8. Sept. 2026, 23:41 UTC

News

Goldman Sachs has agreed to acquire NEOS Investments for $2.25 billion, with shares trading lower in after-market hours following the announcement.

8. Sept. 2026, 23:36 UTC

News
Correlated Moves

Piper Sandler initiated coverage of Quanta Services with an Overweight rating. Shares rose in after-market trading, closing at $624.41.

8. Sept. 2026, 23:36 UTC

News

Shutterstock Inc appointed three new board members to enhance governance. Shares are trading higher after the announcement of Timothy Adams, Matthew Salzberg, and Michael Thompson.

8. Sept. 2026, 23:36 UTC

News

Air Products and Chemicals reported stronger third-quarter profitability, boosting full-year guidance. Shares traded higher in after-market hours following the results.

8. Sept. 2026, 23:31 UTC

News

NetApp shares are trading higher in after-market hours following CEO George Kurian's discussion at the Goldman Sachs Communacopia + Technology Conference.

8. Sept. 2026, 23:31 UTC

News

Estee Lauder Companies announced expanded leadership roles for Brian Franz and Amber English. Shares traded lower during after-market hours following the news.

8. Sept. 2026, 23:21 UTC

News

Prestige Consumer Healthcare Inc shares are lower in after-market trading amid geopolitical tensions and inflation concerns affecting market sentiment across sectors.

8. Sept. 2026, 23:21 UTC

News

Target Corp shares are higher in after-market trading, supported by recent turnaround efforts despite an analyst downgrade to a hold rating.

8. Sept. 2026, 23:21 UTC

News

Tapestry Inc gains in after-market trading, with a market cap of $23.69 billion. A $100 investment five years ago is now worth approximately $290.54.

8. Sept. 2026, 23:16 UTC

News

Stanley Black & Decker shares are higher in after-market trading following the announcement of CEO Chris Nelson's upcoming presentation at a Morgan Stanley conference.

8. Sept. 2026, 23:11 UTC

News

Travel + Leisure Co shares are higher in after-market hours following the announcement of CFO Erik Hoag's participation in a Goldman Sachs conference on September 14, 2026.

8. Sept. 2026, 23:06 UTC

News

Lowe's CEO Marvin R. Ellison will participate in a Goldman Sachs conference on September 15, 2026. Shares are higher in after-market trading.

8. Sept. 2026, 23:06 UTC

Social Media
News
Correlated Moves

Citigroup plans to offer instant cross-border payments using blockchain technology for Japanese firms. Shares are higher in after-market trading following the announcement.

8. Sept. 2026, 23:06 UTC

Social Media
News

General Electric shares rise in after-market hours amid interest in strategic developments, including a $11.75 billion acquisition and potential valuation boost for Precision Castparts.

8. Sept. 2026, 23:06 UTC

News

Eli Lilly's Mounjaro received FDA approval to reduce heart-attack and stroke risk in adults with type 2 diabetes. Shares advanced slightly in after-market trading.

8. Sept. 2026, 23:06 UTC

News

NextEra Energy Inc. shares are trading higher in after-market hours as management announces investor meetings to discuss growth expectations and the Dominion Energy merger.

8. Sept. 2026, 23:06 UTC

News

Merck & Co. shares are higher after Karim Mikhail's appointment to lead the FDA's Center for Biologics Evaluation and Research, boosting the company's regulatory reputation.

8. Sept. 2026, 23:06 UTC

News

General Mills has filed an antitrust lawsuit against major U.S. sugar producers for alleged price collusion, with shares trading higher in after-market hours.

8. Sept. 2026, 23:06 UTC

News

VICI Properties Inc. shares are trading higher in after-market hours following the release of its 2025-2026 Corporate Responsibility Report, highlighting sustainability efforts.

8. Sept. 2026, 23:06 UTC

Event
News

Roivant Sciences Ltd shares are lower in after-market hours despite positive Phase 2 trial results for mosliciguat targeting pulmonary hypertension.

8. Sept. 2026, 23:01 UTC

Social Media
News

AT&T's CEO highlights growth potential and $45B shareholder return plan at Goldman Sachs conference; shares rise in after-market hours.

8. Sept. 2026, 23:01 UTC

News

Ares Capital Corp priced a $750 million public offering of unsecured notes, aiming to enhance financial flexibility. Shares are trading higher in after-market hours.

8. Sept. 2026, 23:01 UTC

News

Constellation Brands plans to redeem $600 million in Senior Notes due 2027, contributing to a rise in shares during after-market trading.

8. Sept. 2026, 23:01 UTC

Correlated Moves
News
Event
Social Media

Braze Inc shares fell sharply in after-hours trading despite strong second-quarter results, as weaker third-quarter EPS guidance raised investor concerns.

8. Sept. 2026, 23:01 UTC

Social Media
News

GameStop shares fell in after-hours trading despite reporting adjusted EPS of $0.27 and raising its fiscal year 2026 EBITDA outlook to over $650 million.

Peer-Vergleich

Kursveränderung

Sartorius Stedim Biotech. Prognose

Kursziel

By TipRanks

26.05% Vorteil

12-Monats-Prognose

Durchschnitt 240 EUR  26.05%

Hoch 260 EUR

Tief 210 EUR

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Sartorius Stedim Biotech. – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

5 ratings

5

Buy

0

Halten

0

Sell

Stimmung

By Acuity

82 / 436 Ranking in Finanzen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
help-icon Live chat